Bowel Cleansing Clinical Trial
Official title:
Efficacy, Safety and Tolerability of a Split-dose of a New Bowel Cleansing Preparation (Eziclen) in Adult Subjects Undergoing Colonoscopy: A Phase III, Multicentre, Randomised, 2 Parallel Group, Comparative Versus Fortrans®, Non-inferiority, Investigator-blinded Study
The purpose of this study is to demonstrate that Eziclen is non-inferior to Fortrans® (the reference colonic lavage in Russia) administered in adult subjects scheduled to undergo colonoscopy for a routinely accepted diagnostic indication.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02630680 -
Eziclen Drug Utilisation in Real Life Setting
|
||
| Completed |
NCT05032794 -
Unrestricted Diet for Screening Colonoscopy
|
N/A | |
| Completed |
NCT02239692 -
A Trial Comparing the PICOPREP Tailored Dosing Schedule to the PICOPREP Day-before Dosing Schedule for Colon Cleansing in Preparation for Colonoscopy
|
Phase 3 | |
| Unknown status |
NCT01481714 -
Efficacy and Safety of Split-dose Citrafleet Administered From 2 to 6 Hours Before Morning Colonoscopies
|
Phase 4 | |
| Recruiting |
NCT04054388 -
LINE Re-education Before Colonoscopy to Confirm Optimal Bowel Cleansing
|
N/A | |
| Completed |
NCT01864915 -
Prucalopride + Prucalopride Booster vs. Prucalopride + Picosalax Booster for the Colon Capsule
|
Phase 3 | |
| Completed |
NCT03631446 -
Drug Use-Results Survey on Picoprep® Combination Powder
|
||
| Recruiting |
NCT05354609 -
DWI MR-enterography Without or With Bowel Cleansing to Assess Intestinal Inflammatory Activity in the Follow-up of Crohn's Disease
|
N/A | |
| Completed |
NCT04852120 -
Compound Sodium Picosulfate Granules for Bowel Preparation in Chinese Population
|